APA (7th ed.) Citation

Deying Yang, Xiang Luo, Qinghai Lian, Lingqiang Gao, Chengxin Wang, Xiaoxiao Qi, . . . Guochao Liao. (2022). Fully synthetic Tn-based three-component cancer vaccine using covalently linked TLR4 ligand MPLA and iNKT cell agonist KRN-7000 as built-in adjuvant effectively protects mice from tumor development. Elsevier.

Chicago Style (17th ed.) Citation

Deying Yang, Xiang Luo, Qinghai Lian, Lingqiang Gao, Chengxin Wang, Xiaoxiao Qi, Rong Zhang, Zhongqiu Liu, and Guochao Liao. Fully Synthetic Tn-based Three-component Cancer Vaccine Using Covalently Linked TLR4 Ligand MPLA and INKT Cell Agonist KRN-7000 as Built-in Adjuvant Effectively Protects Mice from Tumor Development. Elsevier, 2022.

MLA (9th ed.) Citation

Deying Yang, et al. Fully Synthetic Tn-based Three-component Cancer Vaccine Using Covalently Linked TLR4 Ligand MPLA and INKT Cell Agonist KRN-7000 as Built-in Adjuvant Effectively Protects Mice from Tumor Development. Elsevier, 2022.